Scarica l'app Stockscreener
1.67
7.73%
-0.14
Dopo l'orario di chiusura:
1.66
-0.01
-0.60%
Precedente Chiudi:
$1.81
Aprire:
$1.79
Volume 24 ore:
30,534
Relative Volume:
0.32
Capitalizzazione di mercato:
$21.34M
Reddito:
$2.47M
Utile/perdita netta:
$-13.87M
Rapporto P/E:
-1.3689
EPS:
-1.22
Flusso di cassa netto:
$-12.42M
1 W Prestazione:
-18.14%
1M Prestazione:
-15.44%
6M Prestazione:
+17.61%
1 anno Prestazione:
-54.74%
Intervallo 1D:
$1.651
$1.79
Intervallo di 1 settimana:
$1.651
$2.07
Portata 52W:
$1.31
$4.98
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Nome
Collplant Biotechnologies Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta CLGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
1.67 | 23.13M | 2.47M | -13.87M | -12.42M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-02-17 | Iniziato | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Borsa (CLGN) Ultime notizie
What analysts say about CollPlant Biotechnologies Ltd stockMarket Entry Points & Free Stock Predictions and Analysis - earlytimes.in
How CollPlant Biotechnologies Ltd. (CPT) stock trades after earningsWeekly Volume Report & Capital Protection Trading Alerts - Newser
How CollPlant Biotechnologies Ltd. (CPT) stock reacts to monetary easing2025 Geopolitical Influence & Verified Momentum Stock Watchlist - Newser
Can CollPlant Biotechnologies Ltd. stock maintain growth trajectory2025 Top Gainers & Technical Confirmation Trade Alerts - Newser
Is CollPlant Biotechnologies Ltd. (CPT) stock resilient in recession scenariosWall Street Watch & Daily Stock Trend Watchlist - Newser
Can CollPlant Biotechnologies Ltd. stock hit record highs againWeekly Investment Recap & Weekly High Conviction Ideas - Newser
Is CollPlant Biotechnologies Ltd. (CPT) stock a top pick for value investorsJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - Newser
Is CollPlant Biotechnologies Ltd. stock a buy in volatile marketsPortfolio Gains Report & Verified Stock Trade Ideas - Newser
Will CollPlant Biotechnologies Ltd. (CPT) stock deliver stable dividends2025 Price Action Summary & Fast Entry Momentum Alerts - Newser
What MACD trends signal for CollPlant Biotechnologies Ltd. (CPT) stockMarket Trend Review & Verified Technical Signals - Newser
CollPlant Biotechnologies Reports Q3 2025 Financial Results - MSN
Is CollPlant Biotechnologies Ltd. overvalued or undervalued? - Markets Mojo
CollPlant Biotechnologies’ (CLGN) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World
D. Boral Capital Maintains CollPlant Biotechnologies (CLGN) Buy Recommendation - Nasdaq
CLGN Analyst Rating Maintained: November 2025 Update | CLGN Stoc - GuruFocus
CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31 - Investing.com Nigeria
CollPlant Biotechnologies Announces Annual and Extraordinary General Meeting for December 2025 - TipRanks
[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer) | CLGN SEC FilingForm 6-K - Stock Titan
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
CollPlant (CLGN) Sees Significant Q3 Revenue Growth and Advances in Bioprinting - GuruFocus
CLGN Stock Crashed 14% Today – Disappointing Earnings, Workforce Reduction Plan Draws Investor Attention - Stocktwits
CollPlant shares edge down as Q3 revenue falls short of estimates - Investing.com Australia
CollPlant shares edge down as Q3 revenue falls short of estimates By Investing.com - Investing.com South Africa
CollPlant Biotechnologies' Q3 revenue rises on rhCollagen sales, cuts workforce - TradingView
CLGN: Revenue and net loss improved year-over-year, with expanded North American operations and new product milestones - TradingView
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire
CollPlant Biotechnologies's Earnings Outlook - Sahm
Is CollPlant Biotechnologies Ltd a good long term investmentPrice Action Trading & Free Risk Assessment and Control - earlytimes.in
Can CollPlant Biotechnologies Ltd. stock sustain market leadership2025 Top Decliners & Growth Focused Stock Reports - newser.com
Why CollPlant Biotechnologies Ltd. stock is rated strong buy2025 Market Overview & Long-Term Growth Stock Strategies - newser.com
How CollPlant Biotechnologies Ltd. stock trades during market volatility2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
Is CollPlant Biotechnologies Ltd. stock trading at a premium valuation2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Why CollPlant Biotechnologies Ltd. (CPT) stock could be top winner2025 Retail Activity & Target Return Focused Stock Picks - newser.com
Is CollPlant Biotechnologies Ltd. forming a bottoming baseJuly 2025 Retail & Verified Momentum Watchlists - newser.com
How analysts rate CollPlant Biotechnologies Ltd. stock today2025 Market WrapUp & Verified Momentum Stock Watchlist - newser.com
Collplant Biotechnologies Ltd Azioni (CLGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):